Immune tolerance induced by platelet‐targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated
Y. Chen(Fujian Medical University), Qizhen Shi(Children's Hospital of Wisconsin), Jianda Hu(Fujian Medical University), Jocelyn A. Schroeder(Medical College of Wisconsin), Christina K. Baumgartner(AbbVie (United States)), Xiang Luo(Tongji Hospital), J. Chen(Versiti Blood Center of Wisconsin)
Cited by 34
Related Papers
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
|Journal of Clinical Investigation|2006|188
Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia
|Proceedings of the National Academy of Sciences|2017|148